Clinical Trial Update: A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for pacritinib in primary myelofibrosis and myelofibrosis following polycythemia vera or essential thrombocythemia is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myelofibrosis Post-essential Thrombocythemia
• Myelofibrosis Post-polycythemia Vera

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Phase 3 | Status: RECRUITING